Renal cell carcinoma with inferior vena caval involvement A Memorial Sloan-Kettering Cancer Center experience
Gardner, T.A.; Fair, W.R.; Sogani, P.C.; Bains, M.S.; Herr, H.W.; Morse, M.; Russo, P.; Sarkis, A.; Sheinfeld, J.
Journal of Urology 151(5 Suppl): 262A
1994
ISSN/ISBN: 0022-5347 Accession: 033183034
Full Text Article emailed within 1 workday: $29.90
Related References
Motzer, R.J.; Bacik, J.; Mazumdar, M. 2004: Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experience Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(18 Pt 2): 6302s-6303sChoong, C.Victoria.; Tang, T.; Chay, W.Yee.; Goh, C.; Tay, M.Hiang.; Zam, N.Azhari.Mohd.; Tan, P.Hoon.; Tan, M-Han. 2011: Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification Chinese Journal of Cancer 30(2): 144-148
Leibel, S.A.; Armstrong, J.G.; Kutcher, G.J.; Zelefsky, M.J.; Burman, C.M.; Mohan, R.; Ling, C.C.; Fuks, Z. 1996: 3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center Frontiers of Radiation Therapy and Oncology 29: 199-206
Shinohara, N.; Abe, T.; Mochizuki, T.; Kashiwagi, A.; Kanagawa, K.; Maruyama, S.; Sazawa, A.; Oba, K.; Nonomura, K. 2013: Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era? Urologic Oncology 31(7): 1276-1282
Kim, J.Kwon.; Kim, S.Han.; Song, M.Kyung.; Joo, J.; Seo, S.Il.; Kwak, C.; Jeong, C.Wook.; Song, C.; Hwang, E.Chang.; Seo, I.Young.; Lee, H.; Hong, S-Hoo.; Park, J.Young.; Chung, J. 2019: Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry Cancer Research and Treatment: Official Journal of Korean Cancer Association 51(2): 758-768
Williams, J.A.; Cubilla, A.; Maclean, B.J.; Fortner, J.G. 1979: Twenty-two year experience with periampullary carcinoma at Memorial Sloan-Kettering Cancer Center American Journal of Surgery 138(5): 662-665
Tamada, S.; Iguchi, T.; Yasuda, S.; Kato, M.; Yamasaki, T.; Nakatani, T. 2018: The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria Oncotarget 9(45): 27752-27759
Patil, S.; Ishill, N.M.; Deluca, J.; Motzer, R.J. 2016: Trends in Memorial Sloan-Kettering Cancer Center risk group distribution according to treatment year for patients with metastatic renal cell carcinoma (mRCC) Journal of Clinical Oncology 26(15_Suppl): 5092-5092
Gralla, R.J.; Casper, E.S.; Kelsen, D.P.; Chapman, R.A.; Itri, L.M.; Krown, S.E.; Stoopler, M.B.; Lynch, G.R.; Golbey, R.B. 1982: Phase ii studies in non small cell lung cancer the memorial hospital experience memorial sloan kettering cancer center new york city usa 1977 1980 Funes, H C And M Rozencweig (Ed ) Monograph Series Of The European Organization For Research on Treatment Of Cancer (Eortc), Vol 11 New Approaches in Cancer Therapy; Symposium, Madrid, Spain Xvii+185p Raven Press: New York, N Y , Usa Illus P139-146
Choi, D.Xavier.; Van Zee, K.J. 2012: Memorial sloan-kettering cancer center: two decades of experience with ductal carcinoma in situ of the breast International Journal of Surgical Oncology 2012: 723916
Leibel, S.A.; Kutcher, G.J.; Zelefsky, M.J.; Burman, C.M.; Mohan, R.; Ling, C.C.; Fuks, Z. 1996: 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center Frontiers of Radiation Therapy and Oncology 29: 229-237
Zhang, Y.; Li, Y.; Cai, Y.; Wang, K.; Li, H. 2016: Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma Cellular Oncology 39(1): 15-21
Markman, M.; Reichman, B.; Hakes, T.; Hoskins, W.; Rubin, S.; Jones, W.; Lewis, J.L. 1989: Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience) Acta Medica Austriaca 16(3-4): 65-67
de Arruda, F.F.; Puri, D.R.; Zhung, J.; Narayana, A.; Wolden, S.; Hunt, M.; Stambuk, H.; Pfister, D.; Kraus, D.; Shaha, A.; Shah, J.; Lee, N.Y. 2006: Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience International Journal of Radiation Oncology Biology Physics 64(2): 363-373
Sweldens, C.; Peeters, S.; van Limbergen, E.; Janssen, H.; Laenen, A.; Patil, S.; Van Zee, K.J.; Weltens, C. 2014: Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram Cancer Journal 20(1): 1-7